Critical review of controversial issues in the management of advanced pediatric liver tumors

Abha A. Gupta, J. Ted Gerstle, Vicky Ng, Ansely Wong, Annie Fecteau, Marcio Malogolowkin, Rebecka L. Meyers, David Grant, Ronald M. Grant

Research output: Contribution to journalReview article

40 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) and hepatoblastoma (HB) are the most common primary tumors of liver in children. The management of patients with locally advanced, unresectable disease or those with extra-hepatic distant metastases provides substantial challenges to pediatric oncologists, hepatologists, and surgeons. Herein, we critically debate the two sides of three specific controversies: (1) the role of chemotherapy in the treatment of advanced pediatric HCC; (2) the indications for liver transplantation in children with HCC, specifically, the appropriateness of using adult Milan criteria; and (3) the role of liver trasplantation in children with unresectable HB that present with metastatic disease.

Original languageEnglish (US)
Pages (from-to)1013-1018
Number of pages6
JournalPediatric Blood and Cancer
Volume56
Issue number7
DOIs
StatePublished - Jul 1 2011
Externally publishedYes

Fingerprint

Hepatoblastoma
Hepatocellular Carcinoma
Pediatrics
Liver
Neoplasms
Liver Transplantation
Neoplasm Metastasis
Drug Therapy
Therapeutics
Gastroenterologists
Oncologists
Surgeons

Keywords

  • Chemotherapy
  • Hepatoblastoma
  • Hepatocellular carcinoma
  • Liver transplantation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Critical review of controversial issues in the management of advanced pediatric liver tumors. / Gupta, Abha A.; Gerstle, J. Ted; Ng, Vicky; Wong, Ansely; Fecteau, Annie; Malogolowkin, Marcio; Meyers, Rebecka L.; Grant, David; Grant, Ronald M.

In: Pediatric Blood and Cancer, Vol. 56, No. 7, 01.07.2011, p. 1013-1018.

Research output: Contribution to journalReview article

Gupta, AA, Gerstle, JT, Ng, V, Wong, A, Fecteau, A, Malogolowkin, M, Meyers, RL, Grant, D & Grant, RM 2011, 'Critical review of controversial issues in the management of advanced pediatric liver tumors', Pediatric Blood and Cancer, vol. 56, no. 7, pp. 1013-1018. https://doi.org/10.1002/pbc.22893
Gupta, Abha A. ; Gerstle, J. Ted ; Ng, Vicky ; Wong, Ansely ; Fecteau, Annie ; Malogolowkin, Marcio ; Meyers, Rebecka L. ; Grant, David ; Grant, Ronald M. / Critical review of controversial issues in the management of advanced pediatric liver tumors. In: Pediatric Blood and Cancer. 2011 ; Vol. 56, No. 7. pp. 1013-1018.
@article{670778ab6802422d8779169b559f42e7,
title = "Critical review of controversial issues in the management of advanced pediatric liver tumors",
abstract = "Hepatocellular carcinoma (HCC) and hepatoblastoma (HB) are the most common primary tumors of liver in children. The management of patients with locally advanced, unresectable disease or those with extra-hepatic distant metastases provides substantial challenges to pediatric oncologists, hepatologists, and surgeons. Herein, we critically debate the two sides of three specific controversies: (1) the role of chemotherapy in the treatment of advanced pediatric HCC; (2) the indications for liver transplantation in children with HCC, specifically, the appropriateness of using adult Milan criteria; and (3) the role of liver trasplantation in children with unresectable HB that present with metastatic disease.",
keywords = "Chemotherapy, Hepatoblastoma, Hepatocellular carcinoma, Liver transplantation",
author = "Gupta, {Abha A.} and Gerstle, {J. Ted} and Vicky Ng and Ansely Wong and Annie Fecteau and Marcio Malogolowkin and Meyers, {Rebecka L.} and David Grant and Grant, {Ronald M.}",
year = "2011",
month = "7",
day = "1",
doi = "10.1002/pbc.22893",
language = "English (US)",
volume = "56",
pages = "1013--1018",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Critical review of controversial issues in the management of advanced pediatric liver tumors

AU - Gupta, Abha A.

AU - Gerstle, J. Ted

AU - Ng, Vicky

AU - Wong, Ansely

AU - Fecteau, Annie

AU - Malogolowkin, Marcio

AU - Meyers, Rebecka L.

AU - Grant, David

AU - Grant, Ronald M.

PY - 2011/7/1

Y1 - 2011/7/1

N2 - Hepatocellular carcinoma (HCC) and hepatoblastoma (HB) are the most common primary tumors of liver in children. The management of patients with locally advanced, unresectable disease or those with extra-hepatic distant metastases provides substantial challenges to pediatric oncologists, hepatologists, and surgeons. Herein, we critically debate the two sides of three specific controversies: (1) the role of chemotherapy in the treatment of advanced pediatric HCC; (2) the indications for liver transplantation in children with HCC, specifically, the appropriateness of using adult Milan criteria; and (3) the role of liver trasplantation in children with unresectable HB that present with metastatic disease.

AB - Hepatocellular carcinoma (HCC) and hepatoblastoma (HB) are the most common primary tumors of liver in children. The management of patients with locally advanced, unresectable disease or those with extra-hepatic distant metastases provides substantial challenges to pediatric oncologists, hepatologists, and surgeons. Herein, we critically debate the two sides of three specific controversies: (1) the role of chemotherapy in the treatment of advanced pediatric HCC; (2) the indications for liver transplantation in children with HCC, specifically, the appropriateness of using adult Milan criteria; and (3) the role of liver trasplantation in children with unresectable HB that present with metastatic disease.

KW - Chemotherapy

KW - Hepatoblastoma

KW - Hepatocellular carcinoma

KW - Liver transplantation

UR - http://www.scopus.com/inward/record.url?scp=79954494391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954494391&partnerID=8YFLogxK

U2 - 10.1002/pbc.22893

DO - 10.1002/pbc.22893

M3 - Review article

C2 - 21488153

AN - SCOPUS:79954494391

VL - 56

SP - 1013

EP - 1018

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 7

ER -